Advanced Emissions Solutions Reports Fourth Quarter and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
165
Advanced Emissions Solutions Reports Fourth Quarter and Full Year 2016 Results

HIGHLANDS RANCH, Colo., March 13, 2017 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ: ADES ) (the "Company" or "ADES") today filed its Annual Report on Form 10-K and reported financial results for the fourth quarter ended December 31, 2016, including information about its joint-venture partnerships, Tinuum Group, LLC ("Tinuum Group," formerly Clean Coal Solutions, LLC) and Tinuum Services, LLC ("Tinuum Services," formerly Clean Coal Solutions Services, LLC) (collectively "Tinuum"), of which ADES owns 42.5% and 50%, respectively.

Tinuum & Refined Coal (“RC”) Highlights

  • Tinuum distributions to ADES were $14.7 million during the fourth quarter and $46.2 million for full year 2016
  • Royalty earnings from Tinuum Group were $2.2 million during the fourth quarter and $6.1 million for full year 2016
  • Tinuum Group invested tonnage was 10.1 million for the fourth quarter and 41.6 million for full year 2016
  • RC Segment operating income was $51.3 million for full year 2016, an increase of $39.1 million from full year 2015
  • As of December 31, 2016, future expected aggregated rent payments to Tinuum Group were updated to $590 million through the end of 2021
  • Expects to close on new lease with existing investor for an additional RC facility by end of first quarter, which will result in 14 total invested RC facilities

ADES Consolidated Highlights

  • Recognized consolidated revenue of $3.6 million during the fourth quarter and $50.6 million for full year 2016
  • General and administrative operating costs (i.e., non-cost of revenue expenses) for the fourth quarter were $5.4 million and $26.9 million for full year 2016, a reduction of over 59% and 53%, respectively, from the comparable periods in 2015 
  • Consolidated net income was $75.8 million for the fourth quarter and $97.7 million for full year 2016; pretax income was $14.2 million for the fourth quarter and $36.7 million for full year 2016
  • Deferred tax asset valuation allowance decreased $72.4 million due to the 2016 utilization of $11.0 million and fourth quarter release of $61.4 million of our previously recorded deferred tax asset valuation allowance
  • Ended 2016 with a cash balance of $13.2 million, an increase of $5.6 million since September 30, 2016
  • Concluded strategic review process for Emissions Control (“EC”) business with a decision to retain business segment
  • Announced an expected quarterly dividend of $0.25 per share, expected to commence during the second quarter of 2017, if and when declared by our board

L. Heath Sampson, President and CEO of ADES commented, “We set bold and aspirational goals at the beginning of 2016 and I’m proud to say that we exceeded almost all of our strategic priorities throughout the course of the year.  We put legacy issues behind us, we relisted on the NASDAQ exchange, we eliminated our debt and substantially increased our liquidity position. We also exceeded our initial refined coal distribution expectations with the collection of over $45 million during 2016 from our investment in Tinuum.  Lastly, we reduced our operating expenses by over 50% through organizational realignment and enter 2017 with a very lean cost and highly functional organizational structure. I’m very proud of all of our associates at ADES and Tinuum, led by their President and CEO Ron Eller, and I thank them all for their hard work throughout the year in helping us achieve our objectives. Although we closed on a number of new refined coal facilities in 2016, our high expectations were dampened by challenging political headwinds against refined coal production in the U.S. I look forward to capitalizing on the improving 2017 environment and enabling coal fired utilities and tax equity investors to produce cleaner power for the benefit of the American people.”

Sampson continued, “We also have concluded our strategic alternatives review of our EC business at this time.  After a thorough analysis of the assets in the business and the market for our offerings, we have elected to continue to operate EC as a portion of our overall business. While we received a number of inquiries into various components of our portfolio and held many serious conversations with regards to a potential transaction involving the whole business or individual assets held within, we felt that no offer matched the value that we felt was appropriate for this business. We will continue to market and grow our offering within the EC business, while maintaining a lean cost structure that allows the segment to be profitable and stand alone. Additionally, we will continually evaluate other alternatives that support shareholder value."

Fourth Quarter & Full Year Results Fourth quarter revenues and costs of revenues were $3.6 million and $3.5 million, compared with $13.2 million and $7.2 million respectively, in the fourth quarter of 2015. Full year 2016 revenues and costs of revenues were $50.6 million and $39.8 million, compared with $62.7 million and $47.6 million respectively, for full year 2015. The decrease in revenues during both the fourth quarter and full year 2016 was primarily the result of the completion of fewer equipment contracts as the regulatory deadline for compliance has passed, partially offset by an increase in chemical sales.

Fourth quarter other operating expenses were $5.4 million, a decrease of 59% compared to $13.1 million in the fourth quarter of 2015. Full year other operating expenses were $26.9 million, a decrease of 53% compared to $57.0 million for full year 2015. The decreases during both the fourth quarter and full year 2016 were primarily the result of cost containment initiatives, as well as the conclusion of our restatement efforts in the first half of 2016.

Fourth quarter earnings from equity method investments were $15.5 million, compared to $3.8 million for the fourth quarter of 2015.  Full year earnings from equity method investments were $45.6 million, compared to $8.9 million for full year 2015.

Fourth quarter royalty earnings from Tinuum Group were $2.2 million compared to $2.9 million in the fourth quarter of 2015. Full year royalty earnings from Tinuum Group were $6.1 million, compared to $10.6 million for full year 2015. Both fourth quarter and full year 2016 declines were the result of reduced RC tonnage and earnings per ton.

Fourth quarter interest expense was $0.6 million, compared to $3.1 million in the fourth quarter of 2015. Full year interest expense was $5.1 million, compared to $8.4 million for full year 2015. Both fourth quarter and full year 2016 declines were the result of the payoff of the credit agreement during June 2016 and reduced 453A interest expense.

The tax benefit during the fourth quarter was $61.7 million compared to a benefit of $0.1 million in the fourth quarter of 2015. The full year tax benefit was $60.9 million compared to expense of $20 thousand for full year 2015. Both fourth quarter and full year 2016 impacts were the result of a $61.4 million release of our previously recorded deferred tax asset valuation allowance.

Net income for the fourth quarter was $75.8 million, compared to a net loss of $2.9 million in the fourth quarter of 2015. Net income for the full year was $97.7 million, compared to a net loss of $30.1 million for full year 2015.  The increase in net income for both the fourth quarter and the full year 2016 was primarily driven by the release of a portion of our previously recorded deferred tax asset valuation allowance, as well as higher equity income from the RC business and significantly reduced operating expenses in both the EC business and other corporate expenses.

As of December 31, 2016, the Company had cash and cash equivalents of $13.2 million, an increase of 43% compared to $9.3 million as of December 31, 2015.  The Company also had $13.7 million in current and long-term restricted cash as of December 31, 2016, compared to $11.7 million as of December 31, 2015.

2017 Outlook

Sampson added, “We enter 2017 with growing confidence in both our pipeline for RC tax equity investment and in the projected cash flows that our currently invested RC facilities will provide. We also believe that components of the EC business are poised for solid growth moving forward, such as our M-Prove chemicals portfolio. As a result of the strength of our business fundamentals, we’re happy to announce that our board has approved the first ever quarterly dividend program in our history and plans to soon declare the first dividend to be paid under this program. Starting in the second quarter we expect to begin paying a quarterly distribution of $0.25 per share. This quarterly dividend program provides the initial step in what we believe will be a well-balanced capital allocation program and we look forward to driving future shareholder value and executing against our strategic plan in 2017. Future dividends will be paid if and when declared by our board, subject to future capital availability."

Conference Call and Webcast Information The Company has scheduled a conference call to begin at 9:00 a.m. Eastern Time on Tuesday, March 14, 2017.  The conference call will be webcast live via the Investor section of ADES's website at www.advancedemissionssolutions.com . Interested parties may also participate in the call by dialing (877) 201-0168 (Domestic) or (647) 788-4901 (International) conference ID 39354956. A supplemental investor presentation will be available on the Company's investor relations website prior to the start of the conference call.

About Advanced Emissions Solutions, Inc. Advanced Emissions Solutions, Inc. serves as the holding entity for a family of companies that provide emissions solutions to customers in the power generation and other industries.

ADA-ES, Inc. (“ADA”) is a wholly-owned subsidiary of Advanced Emissions Solutions, Inc. (“ADES”) that provides emissions control solutions for coal-fired power generation and industrial boiler industries. With more than 25 years of experience developing advanced mercury control solutions, ADA delivers proprietary environmental technologies, equipment and specialty chemicals that enable coal-fueled boilers to meet emissions regulations. These solutions enhance existing air pollution control equipment, maximizing capacity and improving operating efficiencies.   Our track record includes securing more than 30 US patents for emissions control technology and systems and selling the most activated carbon injection systems for power plant mercury control in North America. For more information on ADA, and its products and services, visit www.adaes.com  or the ADA Blog (http://blog.adaes.com/).

Tinuum Group, LLC is a 42.5% owned joint venture by ADA that provides ADA’s patented Refined Coal (“RC”) CyClean™ technology to enhance combustion of and reduce emissions of NOx and mercury from coals in cyclone boilers and ADA’s patent pending M-45™ and M-45-PC™ technologies for Circulating Fluidized boilers and Pulverized Coal boilers respectively. www.tinuumgroup.com

Caution on Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, which provides a "safe harbor" for such statements in certain circumstances. The forward-looking statements include statements or expectations regarding the timing, availability and content of the presentation; future expected aggregate rent payments to Tinuum Group and its ability to continue to scale its business; expectations on closing of new leases of RC facilities; expectations about the amount and timing of future dividend payments; expectations about future cash flows; and related matters. These statements are based on current expectations, estimates, projections, beliefs and assumptions of the Company’s management. Such statements involve significant risks and uncertainties. Actual events or results could differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to, changes and timing in laws, regulations, IRS interpretations or guidance, accounting rules and any pending court decisions, legal challenges to or repeal of them; changes in prices, economic conditions and market demand; the ability of the RC facilities to produce coal that qualifies for tax credits; the timing, terms and changes in contracts for RC facilities, or failure to lease or sell RC facilities; impact of competition; availability, cost of and demand for alternative tax credit vehicles and other technologies; technical, start-up and operational difficulties; availability of raw materials; loss of key personnel; the value of our products, technologies and intellectual property to customers and strategic investors; intellectual property infringement claims from third parties; seasonality and other factors discussed in greater detail in the Company’s filings with the SEC. You are cautioned not to place undue reliance on such statements and to consult the Company’s SEC filings for additional risks and uncertainties that may apply to our business and the ownership of ADES securities. The Company’s forward-looking statements are presented as of the date made, and the Company disclaims any duty to update such statements unless required by law to do so.

TABLE 1
Advanced Emissions Solutions, Inc. and Subsidiaries
Consolidated Balance Sheets
 
    As of December 31,
(in thousands, except share data)   2016   2015
ASSETS        
Current assets:        
Cash and cash equivalents   $ 13,208     $ 9,265  
Restricted cash   13,736     728  
Receivables, net   8,648     8,361  
Receivables, related parties, net   1,934     1,918  
Costs in excess of billings on uncompleted contracts   25     2,137  
Prepaid expenses and other assets   1,357     2,306  
Total current assets   38,908     24,715  
Restricted cash, long-term   —     10,980  
Property and equipment, net of accumulated depreciation of $2,920 and $4,557   735     2,040  
Investment securities, restricted, long-term   —     336  
Cost method investment   1,016     2,776  
Equity method investments   3,959     17,232  
Deferred tax assets   61,396     —  
Other assets   1,282     2,696  
Total Assets   $ 107,296     $ 60,775  
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)        
Current liabilities:        
Accounts payable   $ 1,920     $ 6,174  
Accrued payroll and related liabilities   2,121     5,800  
Current portion of notes payable, related parties   —     1,837  
Short-term borrowings, net of discount and deferred loan costs, related party   —     12,676  
Billings in excess of costs on uncompleted contracts   4,947     9,708  
Legal settlements and accruals   10,706     6,502  
Other current liabilities   4,017     7,395  
Total current liabilities   23,711     50,092  
Long-term portion of notes payable, related parties   —     13,512  
Legal settlements and accruals, long-term   5,382     13,797  
Other long-term liabilities   2,038     8,352  
Total Liabilities   31,131     85,753  
Commitments and contingencies (Note 14)   —     —  
Stockholders’ equity (deficit):        
Preferred stock: par value of $.001 per share, 50,000,000 shares authorized, none outstanding   —     —  
Common stock: par value of $.001 per share, 100,000,000 shares authorized, 22,322,022 and 21,943,872 shares issued and 22,024,675 and 21,809,164 shares outstanding at December 31, 2016 and 2015, respectively   22     22  
Additional paid-in capital   119,494     116,029  
Accumulated deficit   (43,351 )   (141,029 )
Total stockholders’ equity (deficit)   76,165     (24,978 )
Total Liabilities and Stockholders’ Equity (Deficit)   $ 107,296     $ 60,775  
TABLE 2
Advanced Emissions Solutions, Inc. and Subsidiaries
Consolidated Statements of Operations
 
    December 31,
(in thousands, except per share data)   2016   2015   2014
Revenues:            
Equipment sales   $ 46,949     $ 60,099     $ 12,044  
Chemicals   3,025     888     391  
Consulting services and other   648     1,752     4,488  
Total revenues   50,622     62,739     16,923  
Operating expenses:            
Equipment sales cost of revenue, exclusive of depreciation and amortization   37,741     45,433     9,277  
Chemicals cost of revenue, exclusive of depreciation and amortization   1,700     601     140  
Consulting services and other cost of revenue, exclusive of depreciation and amortization   376     1,518     2,203  
Payroll and benefits   12,390     23,589     20,767  
Rent and occupancy   2,168     3,309     2,468  
Legal and professional fees   8,293     16,604     14,430  
General and administrative   3,721     6,104     6,066  
Research and development, net   (648 )   5,362     1,521  
Depreciation and amortization   979     2,019     1,865  
Total operating expenses   66,720     104,539     58,737  
Operating loss   (16,098 )   (41,800 )   (41,814 )
Other income (expense):            
Earnings from equity method investments   45,584     8,921     42,712  
Royalties, related party   6,125     10,642     6,410  
Interest income   268     24     74  
Interest expense   (5,066 )   (8,402 )   (5,725 )
Litigation settlement and royalty indemnity expense, net   3,464     —     —  
Other   2,463     494     26  
Total other income   52,838     11,679     43,497  
Income (loss) before income tax expense   36,740     (30,121 )   1,683  
Income tax (benefit) expense   (60,938 )   20     296  
Net income (loss)   $ 97,678     $ (30,141 )   $ 1,387  
Earnings (loss) per common share (Note 1):            
Basic   $ 4.40     $ (1.37 )   $ 0.06  
Diluted   $ 4.34     $ (1.37 )   $ 0.06  
Weighted-average number of common shares outstanding:            
Basic   21,931     21,773     21,554  
Diluted   22,234     21,773     22,079  
TABLE 3
Advanced Emissions Solutions, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
 
    Years Ended December 31,
(in thousands)   2016   2015   2014
Cash flows from operating activities            
Net income (loss)   $ 97,678     $ (30,141 )   $ 1,387  
Adjustments to reconcile net income (loss) to net cash used in operating activities:            
Deferred tax benefit   (61,396 )   —     —  
Depreciation and amortization   979     2,019     1,865  
Amortization of debt issuance costs   1,152     987     100  
Debt prepayment penalty   228     —     —  
Impairment of property, equipment, inventory and intangibles   520     2,087     355  
Provision for bad debt expense and note receivable   13     633     500  
Interest costs added to principal balance of notes payable   —     923     1,124  
Consulting expense financed through note payable   —     —     1,600  
Share-based compensation expense   2,868     7,204     4,712  
Clawback of equity awards   —     (325 )   —  
Earnings from equity method investments   (45,584 )   (8,921 )   (42,712 )
Gain on sale of equity method investment   (2,078 )   —     —  
Impairment of cost method investment   1,760     —     —  
Gain on settlement of note payable, licensed technology, and sales-type lease   (1,910 )   —     —  
Other non-cash items, net   35     285     39  
Changes in operating assets and liabilities, net of effects of acquired businesses:            
Receivables   (301 )   8,361     (3,651 )
Related party receivables   (16 )   (479 )   (809 )
Prepaid expenses and other assets   1,195     (107 )   (1,877 )
Costs incurred on uncompleted contracts   29,623     6,492     (56,606 )
Other long-term assets   961     205     (47 )
Accounts payable   (4,254 )   (1,340 )   2,328  
Accrued payroll and related liabilities   (2,887 )   (102 )   686  
Other current liabilities   (3,105 )   (812 )   (672 )
Billings on uncompleted contracts   (32,272 )   (15,186 )   55,621  
Advance deposit, related party   (2,980 )   (3,544 )   (2,135 )
Other long-term liabilities   (2,175 )   595     144  
Legal settlements and accruals   (4,211 )   (3,722 )   (4,622 )
Distributions from equity method investees, return on investment   7,900     5,019     2,509  
Net cash used in operating activities   $ (18,257 )   $ (29,869 )   $ (40,161 )
Cash flows from investing activities            
Distributions from equity method investees in excess of cumulative earnings   38,250     8,651     43,584  
Purchase of investment securities   —     —     (105 )
Maturity of investment securities   —     —     210  
Maturity of investment securities, restricted   336     —     403  
Acquisition of property and equipment   (289 )   (507 )   (1,563 )
Proceeds from sale of property and equipment   52     942     26  
Advance on note receivable   —     (500 )   (500 )
Acquisition of business   —     (2,124 )   —  
    Years Ended December 31,
(in thousands)     2016       2015       2014  
Purchase of cost method investment   —     —     (2,776 )
Purchase of and contributions to equity method investee   (223 )   (2,128 )   (6,631 )
Proceeds from sale of equity method investment   1,773     —     —  
Net cash provided by investing activities   $ 39,899     $ 4,334     $ 32,648  
Cash flows from financing activities            
Short-term borrowings   —     13,539     —  
Repayments on short-term borrowings   (13,250 )   (1,750 )   —  
Repayments on notes payable, related party   (1,246 )   (1,484 )   (238 )
Loan costs and amendment fees   (751 )   —     (70 )
Debt prepayment penalty   (228 )   —     —  
Proceeds received upon exercise of stock options   —     —     243  
Repurchase of shares to satisfy tax withholdings   (196 )   (276 )   (1,500 )
Net cash (used in) provided by financing activities   (15,671 )   10,029     (1,565 )
Increase (Decrease) in Cash and Cash Equivalents and Restricted Cash   5,971     (15,506 )   (9,078 )
Cash and Cash Equivalents and Restricted Cash, beginning of year   20,973     36,479     45,557  
Cash and Cash Equivalents and Restricted Cash, end of year   $ 26,944     $ 20,973     $ 36,479  
Supplemental disclosure of cash flow information:            
Cash paid for interest   $ 3,647     $ 6,274     $ 5,201  
Cash paid for income taxes   541     29     566  
Supplemental disclosure of non-cash investing and financing activities:            
Acquisition of technology license through long-term payable   —     —     1,525  
Acquisition of equity method investment through note payable   —     —     13,301  
Settlement of RCM6 note payable   13,234     —     —  
Non-cash reduction of equity method investment   11,156     —     —  
Stock award reclassification (liability to equity)   899     —     501  
Issuance of common stock to settle liabilities   —     —     127  

 

 

Investor Contact: Alpha IR Group Chris Hodges or Ryan Coleman 312-445-2870 ADES@alpha-ir.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 138

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 58

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 357

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Assessing TJX Companies Inc: Market Sentiment and Performance

Updated Category News Views 199

Understanding TJX Companies Inc's Market Dynamics TJX Companies Inc (NYSE: TJX) is currently navigating an intriguing landscape in the stock market, characterized by an increase in short interest. Notably, the short interest as a percentage of float has surged by 6.82% since the latest report, with approximately 15.68 million shares now sold short. This accounts for 1.41%...

Continue Reading
Refresco Teamsters Achieve Historic Contractual Victory

Updated Category News Views 337

Historic Contract Ratified by Teamsters Local 767 Members of Teamsters Local 767 have made headlines with their recent contract ratification that promises significant improvements for the workers of Refresco. An overwhelming majority of 93 percent voted in favor of this new agreement, showcasing the unity and commitment of the union members. Support for Employees The...

Continue Reading
MAP Medical and Metrix-Secure Team Up for Enhanced Healthcare

Updated Category News Views 133

MAP Medical Partners with Metrix-Secure for Enhanced Services MAP Medical has officially partnered with Metrix-Secure, a recognized leader in the medical supply industry. This collaboration empowers MAP Medical to serve as an authorized distributor, providing quality medical supply solutions to a wide array of healthcare facilities. Enhancing Patient Care with Reliable...

Continue Reading
Investors Show Interest in Unusual Options for Marriott

Updated Category News Views 153

Insights into Unusual Options Activity for Marriott International Recently, there has been a notable surge in bearish sentiment among investors concerning Marriott International (NASDAQ: MAR). This shift in attitude is essential for retail traders to understand as it may indicate changes in the market landscape. These trading patterns were identified through a publicly...

Continue Reading
Caribou Biosciences Investors Have Legal Avenues Available

Updated Category News Views 135

Opportunity for Investors of Caribou Biosciences For those who invested in Caribou Biosciences, Inc. (NASDAQ: CRBU), an exciting opportunity has emerged concerning potential legal claims. The Rosen Law Firm, recognized for its dedication to investor rights, is actively reminding purchasers of Caribou securities of their rights. If you bought securities between July 14,...

Continue Reading